Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

President’s Perspective: Outgoing ACR Leader Audrey B. Uknis, MD, Forecasts Bright Future for Rheumatology

Audrey B. Uknis, MD  |  Issue: October 2013  |  October 1, 2013

Advocacy: Targeted, coordinated, and tireless efforts led by Tim Laing, MD, chair of the Government Affairs Committee, Edward Herzig, MD, chair of RheumPAC, Adam Cooper, ACR director of government affairs, and our lobbyists, including former Senator Tim Hutchinson at Dickstein Shapiro, have succeeded in finding support for our key issues, with legislation being introduced to limit coinsurance for Tier IV medications (H.R. 460, The Patients’ Access to Treatments Act of 2013), and to exempt physician-administered drugs from sequester cuts (H.R. 1416). We continue to work with key committees in Congress, as well as with the Centers for Medicare and Medicaid Services (CMS), to ensure that the Sustainable Growth Rate formula will be repealed and replaced by a menu of options that allow for the appropriate management of patients with chronic, disabling, and life-threatening conditions. Ongoing efforts of the highly successful Simple Tasks campaign facilitate our interactions with Congress, and have worked hand in hand with our robust advocacy efforts. Those of you who know me well have come to expect a healthy dose of skepticism at every turn, but even I am encouraged by the willingness of the staff and leadership of key committees in Congress and CMS to listen to—and even to incorporate—our crucial feedback.

Quality: We look forward to the implementation of our revolutionary electronic health record–enabled registry, RISE, in early 2014. We expect that our unique registry will play a critical role in the design of the practice and payment interface of the future, while it facilitates improvement in quality of care and advances in our understanding of key clinical questions. Our QOC activities will continue to inform the development of RISE and to set the standards for care in our field—critical to our reputation as the principal professional home and quality standard–setting body for the field of rheumatology.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Education and Publication: While we are navigating the complex waters of the heathcare environment, we maintain an unwavering commitment to excellence in feeding the minds of the lifelong learners in our discipline. Positioned as the premier source of education for rheumatology professionals, our education enterprise embraces a philosophy of continuous quality improvement. Our programming offers a broad range of opportunities to review, renew, and update, with networking opportunities at our signature Annual Meeting, our State-of-the-Art Clinical Symposium, or the smaller, more personal Winter Rheumatology Symposium. We have developed a new certification program for musculoskeletal ultrasound, and are providing training programs for varying levels of skill. Education for Maintenance of Certification (MOC) has a home at the ACR, with original programming designed to meet the full range of needs for our members seeking both CME and MOC credit. Web-based programming continues to grow, so busy schedules, varying educational needs, or even location in the world does not limit access to the best education in the field. As our website and learning management technology is enhanced in the coming year, we will have the capability to expand the range and creativity of the programming that will be available worldwide. Similarly, our journals, Arthritis & Rheumatism and Arthritis Care & Research, continue to attract the best science in our field, and they will renew and grow to meet the changing needs and expectations of our members and of our discipline.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:President's Perspective Tagged with:AC&RAdvocacyrheumatology

Related Articles

    New ACR/ARP Committee Members Are Ready to Work

    January 16, 2020

    Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…

    Rocketclips, Inc./shutterstock.com

    Tips for Managing Young Adult Rheumatology Patients

    May 18, 2017

    Often, young adults (18–23 years old) with rheumatic illness demonstrate poor adherence to treatment regimens, lack advocacy skills and have inadequate knowledge about diagnosis and treatment.1 Patients presenting at a transition clinic are typically comfortable with having their parents continue to be centrally involved with their care, but this is a time in life when…

    Meet the 2013 ACR President Audrey B. Uknis, MD

    December 1, 2012

    A rheumatologist and professor at Temple University School of Medicine in Philadelphia, Dr. Uknis was named 2013 president at the American College of Rheumatology (ACR) annual business meeting last month

    2017 ACR/ARHP Honors & Awards, Part 2

    January 19, 2018

    SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting in San Diego in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ARHP winners about their individual contributions. In addition, we profile the new class…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences